Cargando…
Identification of a 24-gene panel and a novel marker of PODXL2 essential for the pathological diagnosis of early prostate cancer
Precise diagnosis of early prostate cancer (PCa) is critical for preventing tumor progression. However, the diagnostic outcomes of currently used markers are far from satisfactory due to the low sensitivity or specificity. Here, we identified a diagnostic subpopulation in PCa tissue with the integra...
Autores principales: | Ma, Xiaoshi, Chen, Lipeng, Chen, Tao, Chen, Kun, Zhang, Huirong, Huang, Kaipeng, Zheng, Han, Jin, Hongtao, Cheng, Zhiqiang, Xiao, Kefeng, Guo, Jinan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Research Network of Computational and Structural Biotechnology
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10663703/ https://www.ncbi.nlm.nih.gov/pubmed/38022698 http://dx.doi.org/10.1016/j.csbj.2023.10.044 |
Ejemplares similares
-
Measurement of serum PODXL concentration for detection of pancreatic cancer
por: Taniuchi, Keisuke, et al.
Publicado: (2018) -
Multifaceted role of RNA editing in promoting loss-of-function of PODXL in cancer
por: Fu, Ting, et al.
Publicado: (2022) -
Identification of a distinct luminal subgroup diagnosing and stratifying early stage prostate cancer by tissue-based single-cell RNA sequencing
por: Ma, Xiaoshi, et al.
Publicado: (2020) -
A comparative study of two PODXL antibodies in 840 colorectal cancer patients
por: Kaprio, Tuomas, et al.
Publicado: (2014) -
Atypical focal segmental glomerulosclerosis associated with a new PODXL nonsense variant
por: Marx, David, et al.
Publicado: (2021)